GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syngene International Ltd (NSE:SYNGENE) » Definitions » Total Assets

Syngene International (NSE:SYNGENE) Total Assets : ₹61,360 Mil (As of Sep. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syngene International Total Assets?

Syngene International's Total Assets for the quarter that ended in Sep. 2024 was ₹61,360 Mil.

During the past 12 months, Syngene International's average Total Assets Growth Rate was 17.40% per year. During the past 3 years, the average Total Assets Growth Rate was 9.90% per year. During the past 5 years, the average Total Assets Growth Rate was 14.10% per year. During the past 10 years, the average Total Assets Growth Rate was 20.40% per year.

During the past 13 years, Syngene International's highest 3-Year average Total Assets Growth Rate was 31.70%. The lowest was 9.20%. And the median was 21.90%.

Total Assets is connected with ROA %. Syngene International's annualized ROA % for the quarter that ended in Sep. 2024 was 6.92%. Total Assets is also linked to Revenue through Asset Turnover. Syngene International's Asset Turnover for the quarter that ended in Sep. 2024 was 0.15.


Syngene International Total Assets Historical Data

The historical data trend for Syngene International's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syngene International Total Assets Chart

Syngene International Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 41,629.00 48,832.00 55,638.00 58,310.00 61,516.00

Syngene International Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 58,462.00 - 61,516.00 - 61,360.00

Syngene International Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Syngene International's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (A: Mar. 2024 )+Total Liabilities (A: Mar. 2024 )
=42577+18939
=61,516

Syngene International's Total Assets for the quarter that ended in Sep. 2024 is calculated as

Total Assets=Total Equity (Q: Sep. 2024 )+Total Liabilities (Q: Sep. 2024 )
=43955+17405
=61,360

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syngene International  (NSE:SYNGENE) Total Assets Explanation

Total Assets is connected with ROA %.

Syngene International's annualized ROA % for the quarter that ended in Sep. 2024 is

ROA %=Net Income (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=4244/( (0+61360)/ 1 )
=4244/61360
=6.92 %

Note: The Net Income data used here is four times the quarterly (Sep. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Syngene International's Asset Turnover for the quarter that ended in Sep. 2024 is

Asset Turnover
=Revenue (Q: Sep. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Sep. 2024 ))/ count )
=8910/( (0+61360)/ 1 )
=8910/61360
=0.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Syngene International Total Assets Related Terms

Thank you for viewing the detailed overview of Syngene International's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


Syngene International Business Description

Traded in Other Exchanges
Address
Jigani Link Road, Biocon SEZ, Biocon Park, Plot No. 2 and 3, IV Phase, Bommasandra Industrial Area, Bangalore, KA, IND, 560 099
Syngene International Ltd is a contract research and manufacturing organization in India. It supports research and development programs, from lead generation to clinical and commercial supplies. The Company is engaged in a single operating segment of providing contract research and manufacturing services. The company operates in India, the United States of America and other countries, of which a majority of the revenue is derived from the US. The company receives revenue by providing contract research and manufacturing services. It offers services such as Oligonucleotide synthesis, Bioinformatics, Clinical development services, polymer research, chemical development, safety assessment, discovery chemistry, discovery biology, and others.

Syngene International Headlines

No Headlines